NanJing Pharmaceutical Company Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 27,301.04 million compared to CNY 23,866.43 million a year ago. Revenue was CNY 27,343.12 million compared to CNY 23,940.99 million a year ago.

Net income was CNY 308.64 million compared to CNY 333.22 million a year ago. Basic earnings per share from continuing operations was CNY 0.237 compared to CNY 0.276 a year ago. Diluted earnings per share from continuing operations was CNY 0.237 compared to CNY 0.276 a year ago.